Klaria Pharma Holding AB (publ.) (KLAR.ST)
SEK 0.29
(-8.63%)
SEK 0.29
(-8.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 5.86 Million | 6.11 Million | 7.22 Million | 4.22 Million | 649 Thousand |
| Cost of Revenue | 9000.00 | - | 10.96 Million | 13.43 Million | - | 9.57 Million |
| Gross Profit | -9000.00 | 5.86 Million | -4.85 Million | -6.21 Million | 4.22 Million | -8.93 Million |
| Operating Expenses | 14.88 Million | 61.3 Million | 80.97 Million | 48.9 Million | 25.33 Million | 27.31 Million |
| Selling, General and Administrative Expenses | 10.44 Million | 10.15 Million | 9.85 Million | 8.29 Million | 8.46 Million | 5.49 Million |
| Research and Development Expenses | 4.45 Million | 51.35 Million | 57.37 Million | 41.22 Million | 16.86 Million | 22.33 Million |
| Other Expenses | - | -203 Thousand | 13.74 Million | -611 Thousand | -1000.00 | -521 Thousand |
| Cost and Expenses | 14.89 Million | 61.3 Million | 80.97 Million | 48.9 Million | 25.33 Million | 27.31 Million |
| Operating Income | -14.68 Million | -54.97 Million | -50.1 Million | -48.73 Million | -21.09 Million | -27.29 Million |
| Interest Expense | 3.77 Million | 7.84 Million | 3.16 Million | 2.56 Million | 1.35 Million | 2000.00 |
| Income Tax Expense | -57 Thousand | 117 Thousand | -11 Thousand | 29 Thousand | 1.35 Million | 13 Thousand |
| Earnings before Tax | -18.44 Million | -63.65 Million | -53.54 Million | -51.41 Million | -22.49 Million | -27.3 Million |
| Net Income | -35.78 Million | -63.77 Million | -53.53 Million | -51.43 Million | -23.84 Million | -27.3 Million |
| Earnings Per Share Basic | -0.36 | -1.10 | -0.97 | -1.11 | -0.72 | -0.83 |
| Earnings Per Share Diluted | -0.36 | -1.10 | -0.97 | -1.11 | -0.72 | -0.83 |
| Weighted Average Shares Outstanding | 99.4 Million | 58.1 Million | 55.25 Million | 46.2 Million | 33.22 Million | 32.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 100.79 Million | 58.1 Million | 55.25 Million | 46.2 Million | 33.22 Million | 32.83 Million |
| Gross Margin | - | 1.00 | -0.79 | -0.86 | 1.00 | -13.76 |
| EBIT Margin | - | -7.63 | -11.44 | -4.91 | -2.62 | -27.31 |
| Profit Margin | - | -10.87 | -8.76 | -7.12 | -5.65 | -42.07 |
| EBITDA | -14.77 Million | -44.78 Million | -39.41 Million | -35.41 Million | -11.05 Million | -17.72 Million |
| Earnings Before Tax Margin | - | -9.37 | -8.20 | -6.75 | -4.99 | -42.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 10 Thousand | - | -7.14 Million | 619 Thousand | - |
| Cost of Revenue | 2000.00 | 2000.00 | 9000.00 | 3000.00 | - | 2.75 Million |
| Gross Profit | -2000.00 | 8000.00 | -9000.00 | -7.15 Million | 619 Thousand | -2.75 Million |
| Operating Expenses | 1.97 Million | 2.81 Million | 14.88 Million | 6.93 Million | 10.25 Million | 9.53 Million |
| Selling, General and Administrative Expenses | 1.43 Million | 1.86 Million | - | 5.41 Million | 2.72 Million | 2.82 Million |
| Research and Development Expenses | 543 Thousand | 948 Thousand | - | 1.52 Million | 7.44 Million | 6.98 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.97 Million | 2.81 Million | 14.89 Million | 6.94 Million | 10.25 Million | 9.53 Million |
| Operating Income | -1.97 Million | -2.81 Million | -14.89 Million | -6.94 Million | -9.63 Million | -9.53 Million |
| Interest Expense | 6.24 Million | 4.31 Million | 3.77 Million | 1.17 Million | 1.12 Million | 597 Thousand |
| Income Tax Expense | 18 Thousand | 4.77 Million | -57 Thousand | -47 Thousand | 45 Thousand | -18 Thousand |
| Earnings before Tax | -8.22 Million | -7.11 Million | -18.44 Million | -7.9 Million | -10.76 Million | -10.12 Million |
| Net Income | -12.41 Million | -11.88 Million | -35.78 Million | -9.47 Million | -10.8 Million | -10.11 Million |
| Earnings Per Share Basic | -0.11 | -0.11 | - | -0.09 | -0.10 | -0.09 |
| Earnings Per Share Diluted | -0.11 | -0.11 | - | -0.09 | -0.10 | -0.09 |
| Weighted Average Shares Outstanding | 118.13 Million | 106.5 Million | 100.79 Million | 106.5 Million | 106.5 Million | 106.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.13 Million | 106.5 Million | 100.79 Million | 106.5 Million | 106.5 Million | 106.5 Million |
| Gross Margin | - | 0.80 | - | 1.00 | 1.00 | - |
| EBIT Margin | - | -281.20 | - | 0.97 | -11.11 | - |
| Profit Margin | - | -1188.60 | - | 1.33 | -17.46 | - |
| EBITDA | -1.97 Million | -2.81 Million | - | -6.93 Million | -6.87 Million | -6.77 Million |
| Earnings Before Tax Margin | - | -281.40 | - | 0.97 | -15.57 | - |
INR
ZNOG
688508
0298
900140
ARWYF